Similar articles

• [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].

  Okagawa K, Iguchi K, Iishi Y, Kosaka M. Okagawa K, et al. Nihon Ketsueki Gakkai Zasshi. 1985 Aug;48(5):1205-13. Nihon Ketsueki Gakkai Zasshi. 1985. PMID: 3934898 Japanese. No abstract available.
• Detection of anti-histone activity in sera of patients with monoclonal gammopathies.

  Shoenfeld Y, el-Roeiy A, Ben-Yehuda O, Pick AI. Shoenfeld Y, et al. Clin Immunol Immunopathol. 1987 Feb;42(2):250-8. doi: 10.1016/0090-1229(87)90012-2. Clin Immunol Immunopathol. 1987. PMID: 3100119
• Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications.

  Mellstedt H, Holm G, Björkholm M. Mellstedt H, et al. Adv Cancer Res. 1984;41:257-89. doi: 10.1016/s0065-230x(08)60018-4. Adv Cancer Res. 1984. PMID: 6428176 Review. No abstract available.
• Perspectives in cancer Research. Specific activities of immunoglobulins produced in monoclonal gammapathy--maladies of derepression.

  Waldenström JG. Waldenström JG. Eur J Cancer (1965). 1976 Jun;12(6):413-8. doi: 10.1016/0014-2964(76)90029-3. Eur J Cancer (1965). 1976. PMID: 821732 No abstract available.
• Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias.

  Merlini G, Farhangi M, Osserman EF. Merlini G, et al. Semin Oncol. 1986 Sep;13(3):350-65. Semin Oncol. 1986. PMID: 3094150 Review. No abstract available.